|
False Claims Act Update & Alert |
||||||
|
Taxpayers
Against Fraud Education Fund | Washington, D.C. |
WWW.TAF.ORG
|
||||||
| | | ||||||
n TAF Home Page n Previous Newsletters n Email editor
|
 House
Judiciary Committee Reports Out FCA BillThe House Judiciary Committee has reported out, by voice vote, H.R. 4854, the False Claims Act Correction Act of 2007. The bill, introduced on December 19, 2007, would clarify and strengthen the False Claims Act which has been weakened by recent court decisions. |
|||||
 Ranbaxy
Under InvestigationRanbaxy is under investigation for making weak or adulterated HIV drugs given to thousands of AIDS patients in Africa and billed to the U.S. Government under the President Emergency Plan for AIDS Relief program (PEPFAR). Ranbaxy is also being investigated for lying about its Zocor formulation sold in the U.S. >> To read more |
||||||
 TX
Joins Lawsuit Against Four Drug CompaniesTexas has recently joined lawsuits against four generic drug manufacturers that falsely reported inflated drug prices to the Texas Medicaid program. The drug companies are Watson/Schein Pharmaceuticals Inc. of California; Alpharma Inc. of New Jersey; Par Pharmaceutical Inc. of New Jersey; and Barr Pharmaceuticals Inc. of New York. The Texas False Claims Act legal action was initiated by Ven-a-Care of the Florida Keys Inc. which has previously initiated Medicare and Medicaid fraud actions that have returned over $850 million to the American people. >> To read more |
||||||
 Dead Docs Stiff TaxpayersA report from the Senate Permanent Subcommittee on Investigations found that from 2000 to 2007, Medicare paid 478,500 claims containing identification numbers that were assigned to deceased physicians. The total amount lost: between $60 million and $92 million. >> To read more |
||||||
 McNulty Memo Will be RevisedAttorney General Michael Mukasey says a 2006 memo written by former Deputy Attorney General Paul McNulty will be revised so that companies under investigation for fraud will no longer be penalized at settlement time if they pay the legal fees of employees under investigation or enter into joint defense agreements with employees. >> To read more |
||||||
|
|
||||||